W. Victoria Lai

SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization

Marina K. Baine, Min‐Shu Hsieh, W. Victoria Lai et al. · Journal of Thoracic Oncology · 2020 · 468 citations · Full text

Immunogenetics, Sclc Subtypes, Histopathologic Characterization +10

Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer

Joseph M. Chan, Àlvaro Quintanal-Villalonga, Vianne R. Gao et al. · Cancer Cell · 2021 · 396 citations · Full text

COVID-19 in patients with lung cancer

Jie Luo, Hira Rizvi, Isabel R. Preeshagul et al. · Annals of Oncology · 2020 · 267 citations · Full text

Medicine, Covid-19 Pandemic, Covid-19 Epidemiology +3

Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study

Luis Paz‐Ares, Stéphane Champiat, W. Victoria Lai et al. · Journal of Clinical Oncology · 2023 · 250 citations · Full text

Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

Justin Jee, Emily S. Lebow, Randy Yeh et al. · Nature Medicine · 2022 · 170 citations · Full text

Tumor Dna-guided Therapy, Overall Survival, Medicine +7